Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR

Trial Profile

Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR

Not yet recruiting
Phase of Trial: Phase 0

Latest Information Update: 30 Jan 2018

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top